<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e2cee-463b-7eb9-a6a8-911b9a10b40c,g:10384bca-9db0-4b9a-acd5-0d2cc00b1451-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="vnda-20260630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e2cee-46e8-796b-abe7-26ec1df834c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e2cee-46e8-7e8f-98da-025620e73849" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e2cee-46e8-796b-abe7-26ec1df834c7" xlink:to="loc_us-gaap_PreferredStockValue_019e2cee-46e8-7e8f-98da-025620e73849" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e2cee-46e8-7158-a180-2e43ba0ca6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e2cee-46e8-796b-abe7-26ec1df834c7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e2cee-46e8-7158-a180-2e43ba0ca6c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e2cee-46e8-7ae7-bc6b-054da2921834" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e2cee-46e8-796b-abe7-26ec1df834c7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e2cee-46e8-7ae7-bc6b-054da2921834" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e2cee-46e8-74e0-8bfe-fe70b6a1ef97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e2cee-46e8-796b-abe7-26ec1df834c7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e2cee-46e8-74e0-8bfe-fe70b6a1ef97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e2cee-46e8-7729-92a9-4cd9185e7d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e2cee-46e8-796b-abe7-26ec1df834c7" xlink:to="loc_us-gaap_CommonStockValue_019e2cee-46e8-7729-92a9-4cd9185e7d1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e2cee-46e8-739b-b086-a81ee02c9e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019e2cee-46e8-7bd2-a0a2-b43add51f585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e2cee-46e8-739b-b086-a81ee02c9e0e" xlink:to="loc_us-gaap_InventoryNet_019e2cee-46e8-7bd2-a0a2-b43add51f585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019e2cee-46e8-7e1c-9efe-139098de9c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e2cee-46e8-739b-b086-a81ee02c9e0e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019e2cee-46e8-7e1c-9efe-139098de9c8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e2cee-46e8-7eb0-8bee-3990b3f7b4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e2cee-46e8-739b-b086-a81ee02c9e0e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e2cee-46e8-7eb0-8bee-3990b3f7b4eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e2cee-46e8-7519-81f8-220fe7c781ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e2cee-46e8-739b-b086-a81ee02c9e0e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e2cee-46e8-7519-81f8-220fe7c781ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_019e2cee-46e8-74fc-b767-74e0e4c84c23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e2cee-46e8-739b-b086-a81ee02c9e0e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_019e2cee-46e8-74fc-b767-74e0e4c84c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e2cee-46e8-792e-a566-f6c00edee567" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2cee-46e8-781b-aaf6-dfbdcdb5be18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2cee-46e8-792e-a566-f6c00edee567" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2cee-46e8-781b-aaf6-dfbdcdb5be18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e2cee-46e8-7bad-b0ad-7bb86c5ec777" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2cee-46e8-792e-a566-f6c00edee567" xlink:to="loc_us-gaap_AssetsCurrent_019e2cee-46e8-7bad-b0ad-7bb86c5ec777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e2cee-46e8-74ed-809c-fc559df6e2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2cee-46e8-792e-a566-f6c00edee567" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e2cee-46e8-74ed-809c-fc559df6e2fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e8-7bdd-bfea-27d627a56875" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2cee-46e8-792e-a566-f6c00edee567" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e8-7bdd-bfea-27d627a56875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_InventoryAndOtherNonCurrent_019e2cee-46e8-7aa4-8fc5-5e1db955350d" xlink:href="vnda-20260630.xsd#vnda_InventoryAndOtherNonCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2cee-46e8-792e-a566-f6c00edee567" xlink:to="loc_vnda_InventoryAndOtherNonCurrent_019e2cee-46e8-7aa4-8fc5-5e1db955350d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_019e2cee-46e8-7705-ba19-94da865807de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2cee-46e8-792e-a566-f6c00edee567" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_019e2cee-46e8-7705-ba19-94da865807de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e2cee-46e8-725b-896e-160b2be3a449" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019e2cee-46e8-716d-b77d-99d8751049ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e2cee-46e8-725b-896e-160b2be3a449" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019e2cee-46e8-716d-b77d-99d8751049ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e2cee-46e8-7544-9dd4-5427d12cd20d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e2cee-46e8-725b-896e-160b2be3a449" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e2cee-46e8-7544-9dd4-5427d12cd20d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e2cee-46e8-7af0-9ece-7ef126fe8ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e2cee-46e8-725b-896e-160b2be3a449" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e2cee-46e8-7af0-9ece-7ef126fe8ef1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019e2cee-46e8-7d3a-a043-d9f1b12b6b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e2cee-46e8-725b-896e-160b2be3a449" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019e2cee-46e8-7d3a-a043-d9f1b12b6b7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2cee-46e8-75ba-8931-2a4c7015abf5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e2cee-46e8-74bd-9eb3-7f8ced28e0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2cee-46e8-75ba-8931-2a4c7015abf5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e2cee-46e8-74bd-9eb3-7f8ced28e0c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e2cee-46e8-7552-aa6f-f20f20192500" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2cee-46e8-75ba-8931-2a4c7015abf5" xlink:to="loc_us-gaap_StockholdersEquity_019e2cee-46e8-7552-aa6f-f20f20192500" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e2cee-46e8-7682-a2c0-a8ff3678d186" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2cee-46e8-75ba-8931-2a4c7015abf5" xlink:to="loc_us-gaap_Liabilities_019e2cee-46e8-7682-a2c0-a8ff3678d186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e2cee-46e8-7847-893b-2a0f718ce1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_ProductRevenueAllowancesCurrent_019e2cee-46e8-79bd-b026-06aba3f5f195" xlink:href="vnda-20260630.xsd#vnda_ProductRevenueAllowancesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e2cee-46e8-7847-893b-2a0f718ce1d1" xlink:to="loc_vnda_ProductRevenueAllowancesCurrent_019e2cee-46e8-79bd-b026-06aba3f5f195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e8-7d3f-8feb-fb375a02c34d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e2cee-46e8-7847-893b-2a0f718ce1d1" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e8-7d3f-8feb-fb375a02c34d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="vnda-20260630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2cee-46e9-7d30-b408-cbed401d59ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2cee-46e9-7a75-9c6a-98d560403365" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2cee-46e9-7d30-b408-cbed401d59ac" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2cee-46e9-7a75-9c6a-98d560403365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019e2cee-46e9-7b4f-aaf9-2c7fb9e83ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2cee-46e9-7d30-b408-cbed401d59ac" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019e2cee-46e9-7b4f-aaf9-2c7fb9e83ec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019e2cee-46e9-7879-9ad1-a332813197ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e2cee-46e9-71f8-b6f7-aadbc4fbb81b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019e2cee-46e9-7879-9ad1-a332813197ee" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e2cee-46e9-71f8-b6f7-aadbc4fbb81b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e2cee-46e9-7d27-8a4e-1e656935d334" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019e2cee-46e9-7879-9ad1-a332813197ee" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e2cee-46e9-7d27-8a4e-1e656935d334" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e2cee-46e9-754a-bd09-76c4b5a1d43f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019e2cee-46e9-7879-9ad1-a332813197ee" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e2cee-46e9-754a-bd09-76c4b5a1d43f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_019e2cee-46e9-72a8-b5d4-7851adcd7f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019e2cee-46e9-7879-9ad1-a332813197ee" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_019e2cee-46e9-72a8-b5d4-7851adcd7f3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019e2cee-46e8-7259-9acc-a76ad954093b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2cee-46e8-74d1-b391-636dc5770abb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_019e2cee-46e8-7259-9acc-a76ad954093b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2cee-46e8-74d1-b391-636dc5770abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e2cee-46e8-7884-89a5-adfdab1c8025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019e2cee-46e8-7e18-acf4-9afdd9c83563" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e2cee-46e8-7884-89a5-adfdab1c8025" xlink:to="loc_us-gaap_Revenues_019e2cee-46e8-7e18-acf4-9afdd9c83563" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019e2cee-46e9-72cc-955c-32304316e16e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e2cee-46e8-7884-89a5-adfdab1c8025" xlink:to="loc_us-gaap_CostsAndExpenses_019e2cee-46e9-72cc-955c-32304316e16e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2cee-46e9-7f69-8142-a30d86c5df63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e2cee-46e9-7008-9d38-a938c5b63330" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2cee-46e9-7f69-8142-a30d86c5df63" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e2cee-46e9-7008-9d38-a938c5b63330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_019e2cee-46e9-7fc5-b8b0-ab5b86452b18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2cee-46e9-7f69-8142-a30d86c5df63" xlink:to="loc_us-gaap_OtherIncome_019e2cee-46e9-7fc5-b8b0-ab5b86452b18" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" xlink:type="simple" xlink:href="vnda-20260630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e2cee-46e9-7c0d-99cf-cdfcc6266d28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_019e2cee-46e9-7a53-a509-0874fb268a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e2cee-46e9-7c0d-99cf-cdfcc6266d28" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_019e2cee-46e9-7a53-a509-0874fb268a8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_019e2cee-46e9-741c-a2a2-e844eef5570a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e2cee-46e9-7c0d-99cf-cdfcc6266d28" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_019e2cee-46e9-741c-a2a2-e844eef5570a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_019e2cee-46e9-7e41-9902-74bedd37b754" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e2cee-46e9-7c0d-99cf-cdfcc6266d28" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_019e2cee-46e9-7e41-9902-74bedd37b754" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e2cee-46e9-74ac-878d-773656d2625a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2cee-46e9-760c-8e2e-9934095b5328" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e2cee-46e9-74ac-878d-773656d2625a" xlink:to="loc_us-gaap_NetIncomeLoss_019e2cee-46e9-760c-8e2e-9934095b5328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e2cee-46e9-7571-9961-fb10b4f86d60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e2cee-46e9-74ac-878d-773656d2625a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e2cee-46e9-7571-9961-fb10b4f86d60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="vnda-20260630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2cee-46e9-764f-968f-295e8392161e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019e2cee-46e9-72c7-bfe9-cbb6b18d71d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2cee-46e9-764f-968f-295e8392161e" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019e2cee-46e9-72c7-bfe9-cbb6b18d71d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_019e2cee-46e9-781d-bd84-ddcb63ae3c15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2cee-46e9-764f-968f-295e8392161e" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_019e2cee-46e9-781d-bd84-ddcb63ae3c15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2cee-46e9-74c0-91e7-4c37ac504315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019e2cee-46e9-78fe-97b9-7b6906bf6461" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2cee-46e9-74c0-91e7-4c37ac504315" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019e2cee-46e9-78fe-97b9-7b6906bf6461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e2cee-46e9-7f57-bd33-cfe04d6743e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2cee-46e9-74c0-91e7-4c37ac504315" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e2cee-46e9-7f57-bd33-cfe04d6743e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_019e2cee-46e9-7770-b54f-894f275dac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2cee-46e9-74c0-91e7-4c37ac504315" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_019e2cee-46e9-7770-b54f-894f275dac1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_019e2cee-46e9-7f48-bf97-b450f189d582" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2cee-46e9-74c0-91e7-4c37ac504315" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_019e2cee-46e9-7f48-bf97-b450f189d582" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2cee-46e9-7b40-8a25-4a1041bbcb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_NetIncomeLoss_019e2cee-46e9-7b40-8a25-4a1041bbcb0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019e2cee-46e9-7d2d-90ee-03781a85787a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_Depreciation_019e2cee-46e9-7d2d-90ee-03781a85787a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e2cee-46e9-7c0f-a9b4-5402920c6b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_ShareBasedCompensation_019e2cee-46e9-7c0f-a9b4-5402920c6b9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_019e2cee-46e9-7fef-900e-1014b63ca64e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_019e2cee-46e9-7fef-900e-1014b63ca64e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_019e2cee-46e9-7410-b917-5e0d18cbe57f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_019e2cee-46e9-7410-b917-5e0d18cbe57f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_LeaseRightOfUseAssetPeriodicReductionAndAmortization_019e2cee-46e9-73c1-8b1c-4c11bf013689" xlink:href="vnda-20260630.xsd#vnda_LeaseRightOfUseAssetPeriodicReductionAndAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_vnda_LeaseRightOfUseAssetPeriodicReductionAndAmortization_019e2cee-46e9-73c1-8b1c-4c11bf013689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019e2cee-46e9-76e6-9dbc-9074b7ef74ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019e2cee-46e9-76e6-9dbc-9074b7ef74ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_019e2cee-46e9-7203-9200-a631773a79ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_019e2cee-46e9-7203-9200-a631773a79ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019e2cee-46e9-7148-a65a-debcea15c6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019e2cee-46e9-7148-a65a-debcea15c6b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e2cee-46e9-7d55-813a-d0e2f8792666" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e2cee-46e9-7d55-813a-d0e2f8792666" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_019e2cee-46e9-7c9d-a62f-06013ad18ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_019e2cee-46e9-7c9d-a62f-06013ad18ea2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019e2cee-46e9-7188-b100-eb816680cac1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019e2cee-46e9-7188-b100-eb816680cac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_IncreaseDecreaseProductRevenueAllowances_019e2cee-46e9-76ba-b108-73f5c8ae73ae" xlink:href="vnda-20260630.xsd#vnda_IncreaseDecreaseProductRevenueAllowances"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-720c-bccc-51da505db168" xlink:to="loc_vnda_IncreaseDecreaseProductRevenueAllowances_019e2cee-46e9-76ba-b108-73f5c8ae73ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2cee-46e9-7dc9-8ec3-f7aa5ca251f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-74c7-ad51-48d4458ffcbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2cee-46e9-7dc9-8ec3-f7aa5ca251f8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2cee-46e9-74c7-ad51-48d4458ffcbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2cee-46e9-7370-90fe-c450406a93cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2cee-46e9-7dc9-8ec3-f7aa5ca251f8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2cee-46e9-7370-90fe-c450406a93cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e2cee-46e9-7aad-9afd-20ee6a24e92a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2cee-46e9-7dc9-8ec3-f7aa5ca251f8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e2cee-46e9-7aad-9afd-20ee6a24e92a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2cee-46e9-7e98-bc38-c86f646a0dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2cee-46e9-7dc9-8ec3-f7aa5ca251f8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2cee-46e9-7e98-bc38-c86f646a0dd4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="vnda-20260630.xsd#SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/SummaryofSignificantAccountingPoliciesScheduleofReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e2cee-46e9-7cd4-960a-a755d63b82d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e2cee-46e9-7751-a476-830a4ceac98e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e2cee-46e9-7cd4-960a-a755d63b82d7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e2cee-46e9-7751-a476-830a4ceac98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_019e2cee-46e9-75ec-8ee6-eaae0f6fba50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e2cee-46e9-7cd4-960a-a755d63b82d7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_019e2cee-46e9-75ec-8ee6-eaae0f6fba50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019e2cee-46e9-7c1b-9211-939aab78e0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e2cee-46e9-7cd4-960a-a755d63b82d7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_019e2cee-46e9-7c1b-9211-939aab78e0bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/MarketableSecuritiesDetails" xlink:type="simple" xlink:href="vnda-20260630.xsd#MarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/MarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_019e2cee-46e9-78ce-a787-bb519e028864" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e2cee-46e9-785e-86bb-8d4c45aada26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_019e2cee-46e9-78ce-a787-bb519e028864" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e2cee-46e9-785e-86bb-8d4c45aada26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e2cee-46e9-7ff3-b3b1-c5f667d8deaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_019e2cee-46e9-78ce-a787-bb519e028864" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e2cee-46e9-7ff3-b3b1-c5f667d8deaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_019e2cee-46e9-715f-9920-92b78c7b7669" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_019e2cee-46e9-78ce-a787-bb519e028864" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_019e2cee-46e9-715f-9920-92b78c7b7669" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/FairValueMeasurementsScheduleofAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="vnda-20260630.xsd#FairValueMeasurementsScheduleofAssetsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/FairValueMeasurementsScheduleofAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019e2cee-46e9-731c-be64-97f26661480e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_019e2cee-46e9-74a3-a9f9-c59f7951ecfd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019e2cee-46e9-731c-be64-97f26661480e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_019e2cee-46e9-74a3-a9f9-c59f7951ecfd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/InventoryScheduleofInventoryDetails" xlink:type="simple" xlink:href="vnda-20260630.xsd#InventoryScheduleofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/InventoryScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019e2cee-46e9-7986-8b2c-41035c297065" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_019f80b3-e1d0-7386-9fab-0d618c273861" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019e2cee-46e9-7986-8b2c-41035c297065" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_019f80b3-e1d0-7386-9fab-0d618c273861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_019e2cee-46e9-73c2-ae89-976610ddb56b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019e2cee-46e9-7986-8b2c-41035c297065" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_019e2cee-46e9-73c2-ae89-976610ddb56b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_019e2cee-46e9-73a8-b779-a3af225b3172" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_InventoryRawMaterialsNetOfReservesNonCurrent_019e2cee-46e9-750c-878f-23c6bed1311e" xlink:href="vnda-20260630.xsd#vnda_InventoryRawMaterialsNetOfReservesNonCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNoncurrent_019e2cee-46e9-73a8-b779-a3af225b3172" xlink:to="loc_vnda_InventoryRawMaterialsNetOfReservesNonCurrent_019e2cee-46e9-750c-878f-23c6bed1311e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_InventoryWorkInProcessNetOfReservesNonCurrent_019e2cee-46e9-7b1a-8d1d-f893e95e1a80" xlink:href="vnda-20260630.xsd#vnda_InventoryWorkInProcessNetOfReservesNonCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNoncurrent_019e2cee-46e9-73a8-b779-a3af225b3172" xlink:to="loc_vnda_InventoryWorkInProcessNetOfReservesNonCurrent_019e2cee-46e9-7b1a-8d1d-f893e95e1a80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_InventoryFinishedGoodsNetOfReservesNonCurrent_019e2cee-46e9-7434-bf83-55c9c0b20df2" xlink:href="vnda-20260630.xsd#vnda_InventoryFinishedGoodsNetOfReservesNonCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNoncurrent_019e2cee-46e9-73a8-b779-a3af225b3172" xlink:to="loc_vnda_InventoryFinishedGoodsNetOfReservesNonCurrent_019e2cee-46e9-7434-bf83-55c9c0b20df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_Inventory_019e2cee-46e9-72de-b34b-cbba912da6e0" xlink:href="vnda-20260630.xsd#vnda_Inventory"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_019e2cee-46e9-7977-a9a1-5f5cd0007a82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_vnda_Inventory_019e2cee-46e9-72de-b34b-cbba912da6e0" xlink:to="loc_us-gaap_InventoryNoncurrent_019e2cee-46e9-7977-a9a1-5f5cd0007a82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019e2cee-46e9-7de9-8eb3-e0c1ec2fa10a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_vnda_Inventory_019e2cee-46e9-72de-b34b-cbba912da6e0" xlink:to="loc_us-gaap_InventoryNet_019e2cee-46e9-7de9-8eb3-e0c1ec2fa10a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="vnda-20260630.xsd#IntangibleAssetsScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-7842-9318-280abbd6621b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019e2cee-46e9-7ac8-9e8c-fdbd5c254384" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-7842-9318-280abbd6621b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019e2cee-46e9-7ac8-9e8c-fdbd5c254384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019e2cee-46e9-7f10-8346-975aa7775f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-7842-9318-280abbd6621b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019e2cee-46e9-7f10-8346-975aa7775f2f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/IntangibleAssetsScheduleofFutureIntangibleAssetAmortizationDetails" xlink:type="simple" xlink:href="vnda-20260630.xsd#IntangibleAssetsScheduleofFutureIntangibleAssetAmortizationDetails"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/IntangibleAssetsScheduleofFutureIntangibleAssetAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-722e-a8b1-13a10a5e7ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_019e2cee-46e9-76af-8783-b5067985ad0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-722e-a8b1-13a10a5e7ea2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_019e2cee-46e9-76af-8783-b5067985ad0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_019e2cee-46e9-756d-8bc1-91b8efece2ac" xlink:href="vnda-20260630.xsd#vnda_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-722e-a8b1-13a10a5e7ea2" xlink:to="loc_vnda_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_019e2cee-46e9-756d-8bc1-91b8efece2ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_019e2cee-46e9-73ec-b5b5-3622b0453a68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-722e-a8b1-13a10a5e7ea2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_019e2cee-46e9-73ec-b5b5-3622b0453a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_019e2cee-46e9-7a6b-8cbc-d5279ace12de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-722e-a8b1-13a10a5e7ea2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_019e2cee-46e9-7a6b-8cbc-d5279ace12de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_019e2cee-46e9-7eff-aa38-0d7b4d8d0534" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-722e-a8b1-13a10a5e7ea2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_019e2cee-46e9-7eff-aa38-0d7b4d8d0534" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_019e2cee-46e9-76f5-96c3-b9d92687f27e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2cee-46e9-722e-a8b1-13a10a5e7ea2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_019e2cee-46e9-76f5-96c3-b9d92687f27e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/AccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="vnda-20260630.xsd#AccountsPayableandAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/AccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e9-7a99-93e2-9aad132cbc87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_AccruedResearchAndDevelopmentExpense_019e2cee-46e9-7677-838b-45bc9bdc53cf" xlink:href="vnda-20260630.xsd#vnda_AccruedResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e9-7a99-93e2-9aad132cbc87" xlink:to="loc_vnda_AccruedResearchAndDevelopmentExpense_019e2cee-46e9-7677-838b-45bc9bdc53cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019e2cee-46e9-74eb-824e-477a6b2d7c45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e9-7a99-93e2-9aad132cbc87" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019e2cee-46e9-74eb-824e-477a6b2d7c45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e2cee-46e9-70a6-8f28-cd774f352e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e9-7a99-93e2-9aad132cbc87" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e2cee-46e9-70a6-8f28-cd774f352e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vnda_AccruedMilestoneObligationsUnderLicenseAgreements_019e2cee-46e9-7a8b-b86c-d12140dac6a7" xlink:href="vnda-20260630.xsd#vnda_AccruedMilestoneObligationsUnderLicenseAgreements"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e9-7a99-93e2-9aad132cbc87" xlink:to="loc_vnda_AccruedMilestoneObligationsUnderLicenseAgreements_019e2cee-46e9-7a8b-b86c-d12140dac6a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_019e2cee-46e9-78a4-ae1d-aad771c908ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e9-7a99-93e2-9aad132cbc87" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_019e2cee-46e9-78a4-ae1d-aad771c908ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e2cee-46e9-7f6f-bffa-aa88488bc050" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e9-7a99-93e2-9aad132cbc87" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e2cee-46e9-7f6f-bffa-aa88488bc050" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_019e2cee-46e9-7a89-b791-499e11e33ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e9-7a99-93e2-9aad132cbc87" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_019e2cee-46e9-7a89-b791-499e11e33ec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_019e2cee-46e9-7e82-8f38-370aebaac779" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019e2cee-46e9-7a99-93e2-9aad132cbc87" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_019e2cee-46e9-7e82-8f38-370aebaac779" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="vnda-20260630.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e2cee-479e-7385-a28d-f7904b0eb12f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_019e2cee-479e-7c0d-9434-892c5c85ed0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e2cee-479e-7385-a28d-f7904b0eb12f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_019e2cee-479e-7c0d-9434-892c5c85ed0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_019e2cee-479e-7edc-9866-014408b4987d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e2cee-479e-7385-a28d-f7904b0eb12f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_019e2cee-479e-7edc-9866-014408b4987d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.vandapharmaceuticals.com/role/SegmentsScheduleofSegmentRevenueandSignificantExpensesDetails" xlink:type="simple" xlink:href="vnda-20260630.xsd#SegmentsScheduleofSegmentRevenueandSignificantExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.vandapharmaceuticals.com/role/SegmentsScheduleofSegmentRevenueandSignificantExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2cee-479e-7474-b568-0709a0683e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019e2cee-479e-7c0e-87bf-1d2296d3eb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2cee-479e-7474-b568-0709a0683e6d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019e2cee-479e-7c0e-87bf-1d2296d3eb4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e2cee-479e-762a-9f74-759a076af1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2cee-479e-7474-b568-0709a0683e6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e2cee-479e-762a-9f74-759a076af1d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e2cee-479e-778d-a61a-5082b42bd65b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2cee-479e-7474-b568-0709a0683e6d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e2cee-479e-778d-a61a-5082b42bd65b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019e2cee-479e-7139-b1f7-3562ab7c1512" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2cee-479e-7474-b568-0709a0683e6d" xlink:to="loc_us-gaap_Revenues_019e2cee-479e-7139-b1f7-3562ab7c1512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e2cee-479e-7e0d-8fa0-1ef781b33957" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2cee-479e-7474-b568-0709a0683e6d" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e2cee-479e-7e0d-8fa0-1ef781b33957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_019e2cee-479e-7126-8abe-409c7ed2e83c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2cee-479e-7474-b568-0709a0683e6d" xlink:to="loc_us-gaap_OtherIncome_019e2cee-479e-7126-8abe-409c7ed2e83c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_019e2cee-479e-7452-b7c5-058409f7c364" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2cee-479e-7474-b568-0709a0683e6d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_019e2cee-479e-7452-b7c5-058409f7c364" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
